To confirm the broad and potent coverage of disease-relevant KIT mutations indicated by biochemical assays and in cell lines with transgenic overexpression, cellular activity of M4205 was investigated in cancer cell lines expressing disease-relevant endogenous KIT mutations. This evidence concerns the gene KIT and cancer.